Cisplatin (Athenex Pharmaceutical Division, LLC.)


Welcome to the PulseAid listing for the Cisplatin drug offered from Athenex Pharmaceutical Division, LLC.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Athenex Pharmaceutical Division, LLC.
NON-PROPRIETARY NAME: cisplatin
SUBSTANCE NAME: CISPLATIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-06-12
END MARKETING DATE: 0000-00-00


Cisplatin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCisplatin from Athenex Pharmaceutical Division, LLC.
LABELER NAME: Athenex Pharmaceutical Division, LLC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2017-06-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70860-206_a441523a-d500-4e5f-b14f-344d139cbb29
PRODUCT NDC: 70860-206
APPLICATION NUMBER: ANDA207323

Other CISPLATIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.Cisplatin
Alvogen Inc.Cisplatin
Athenex Pharmaceutical Division, LLC.Cisplatin
BluePoint LaboratoriesCisplatin
Corden Pharma Latina S.p.A.Platinol
Fresenius Kabi USA, LLCCisplatin
Gland Pharma LimitedCISPLATIN
Mylan Institutional LLCCisplatin
Pfizer Laboratories Div Pfizer Inc.Cisplatin
Teva Parenteral Medicines, Inc.Cisplatin
WG Critical Care, LLCCISplatin